Profile data is unavailable for this security.
About the company
New Ray Medicine International Holding Ltd is an investment holding company principally engaged in the distribution and trading of pharmaceutical and the provision of marketing and promotion services. The Company operates its businesses through two segments. The Distribution and Trading of Pharmaceutical and Related Products segment is mainly engaged in the distribution and trading of drugs and chemical reagents for pharmaceutical. The Provision of Marketing and Promotion Services segment is mainly engaged in the provision of marketing and promotion services of drugs and chemical reagents for pharmaceutical. The Company mainly operates its businesses in the domestic market.
- Revenue in HKD (TTM)121.93m
- Net income in HKD-34.38m
- Incorporated2012
- Employees30.00
- LocationNew Ray Medicine International Holding LtdRoom 3702-03, Dikai International CenterNo. 19 Dangui RoadHANGZHOU ChinaCHN
- Websitehttp://www.newraymedicine.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| New Ray Medicine International Holding | 121.93m | -34.38m | 48.55m | 30.00 | -- | 0.0953 | -- | 0.3982 | -0.2056 | -0.2056 | 0.7293 | 2.54 | 0.2587 | 6.99 | 1.79 | 4,204,414.00 | -7.30 | -6.94 | -7.60 | -7.15 | -3.45 | 2.04 | -28.20 | -29.00 | 18.20 | -- | 0.0056 | -- | 87.31 | -4.56 | -39.89 | -- | -11.99 | -- |
| Cosmos Chouzai Pharmacy Co Ltd | -5.12bn | -5.12bn | 108.38m | 220.00 | -- | 2.00 | -- | -- | -- | -- | -- | 349.42 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.22 | -- | 0.4173 | -- | 1.71 | -- | 430.77 | -- | -- | -- |
| F&F Inc | 303.61m | 11.92m | 146.92m | 190.00 | 8.04 | 2.87 | 8.67 | 0.4839 | 775.83 | 775.83 | 19,759.39 | 2,172.93 | 1.84 | 13.67 | 7.52 | 31,219,840.00 | 7.23 | -- | 12.81 | -- | 23.83 | -- | 3.93 | -- | 1.08 | 49.32 | 0.4982 | -- | 1.28 | -- | 69.21 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to New Ray Medicine International Holding Ltd's reporting currency: Hong Kong Dollar HKD
